https://european-biotechnology.com/wp-content/uploads/2024/04/Biovector_Pharma.jpg7201280Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2022-08-16 07:18:002024-04-04 16:46:08Vector Biopharma kicks of with CHF30m Series A financing
https://european-biotechnology.com/wp-content/uploads/2024/04/B-Medical-Systems-Factory-Lux-Wort-10.jpeg16152422Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2022-08-09 15:46:272024-04-04 16:46:10Azenta set to acquire B Medical Systems
Sartorius Stedim Biotech has purchased the world’s largest human albumin producer Albumedix to broaden its product portfolio in animal-free cell media and to stabilise protein drugs.
https://european-biotechnology.com/wp-content/uploads/2024/04/Albumedix.jpg400800Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2022-08-09 07:45:092024-04-04 16:46:11Sartorius pays £415m for Albumedix Ltd
As Genmab’s Hexabody tumour antibody platform is advancing, BioNTech has secured a licence in the field of immunotherapy to co-develop antibodies on 50:50 base.
https://european-biotechnology.com/wp-content/uploads/2024/04/Pulmonary_aspergillosis.jpg6831024Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2022-08-04 09:05:312024-04-04 16:46:13F2G to use $70m financing to advance olorofilm
https://european-biotechnology.com/wp-content/uploads/2024/04/Biofilm.jpg533800Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2022-08-01 14:51:002024-04-04 16:46:15UK-Spanish team to optimise efficacy of microbial production processes
InflaRx plans to apply for Emergency Use Authorization from the US FDA in Q3/2022 for vilobelimab, the company’s treatment for critically ill COVID-19 patients.
https://european-biotechnology.com/wp-content/uploads/2024/04/Bildschirmfoto_2022-07-27_um_07.42.18.png163519Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2022-07-26 15:06:172024-04-04 16:46:16InflaRX set to file for MAA for vilobelimab
Largest beer brewer to use sustainable PEF bottles
Latest NewsAvantium and AmBev, part of AB InBev Group, have inked an agreement on PEF for soft drink bottles.
Vector Biopharma kicks of with CHF30m Series A financing
Latest NewsWith a Series A funding of CHF 30m from Versant Ventures, Vector Biopharma AG set out to solve several of the current gene delivery problems.
Two deaths with Novartis gene therapy
Latest NewsSwiss-headquarterd Novartis AG has reported two cases of fatal liver failure after treatment with the gene therapy Zolgensma.
Azenta set to acquire B Medical Systems
Latest NewsAzenta Inc has entered into an agreement to acquire B Medical Systems S.á r.l. and its subsidiaries for €410m.
Sartorius pays £415m for Albumedix Ltd
Latest NewsSartorius Stedim Biotech has purchased the world’s largest human albumin producer Albumedix to broaden its product portfolio in animal-free cell media and to stabilise protein drugs.
BioNtech SE expands collab with Genmab A/S
Latest NewsAs Genmab’s Hexabody tumour antibody platform is advancing, BioNTech has secured a licence in the field of immunotherapy to co-develop antibodies on 50:50 base.
F2G to use $70m financing to advance olorofilm
Latest NewsBritish antifungal developer F2G Ltd has announced a $70mn financing round to push development of its late-stage compound olorofilm.
Sosei announces $1.2bn R&D collaboration with Abbvie
Latest NewsSosei Heptares and AbbVie have inked a multi-target licence option drug discovery agreement in neurology.
UK-Spanish team to optimise efficacy of microbial production processes
Latest NewsResearchers have presented a novel method to promote biofilm formation and thus to increase efficiency of biocatalysis in biotech production.
InflaRX set to file for MAA for vilobelimab
Latest NewsInflaRx plans to apply for Emergency Use Authorization from the US FDA in Q3/2022 for vilobelimab, the company’s treatment for critically ill COVID-19 patients.